World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
18583
World Ranking
18176
National Ranking
199

Søren Friis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Søren Friis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 354 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Søren Friis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Søren Friis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Søren Friis is affiliated with the University of Copenhagen in Denmark. Their research contributions span several topics within medical and pharmacological fields, notably focusing on clinical and epidemiological aspects of cancer and drug interactions.

The scientist's publication record includes recent papers in notable journals and repositories:

  • 184O The risk of late breast cancer recurrence in Denmark during 17 years of follow-up, 2020, Annals of Oncology
  • Stage-specific survival among men with prostate cancer in the Nordic countries 2004-2016 - the NORDCAN survival studies, 2024, European Urology
  • Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations, 2024, UNC Libraries
  • External adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk, 2024, UNC Libraries

Frequent collaborators with Søren Friis include the following researchers:

  • Anton Pottegård
  • Til Stürmer
  • Jesper Hallas
  • Rikke Nørgaard Pedersen
  • Buket Öztürk

The publications from Friis and co-authors have appeared predominantly in these venues:

  • UNC Libraries
  • Annals of Oncology
  • European Urology

Their research fields incorporate several sub-disciplines including:

  • Pulmonary and Respiratory Medicine
  • Statistics and Probability
  • Pharmacology

Topic areas covered by the scientist's work include:

  • Lung Cancer Treatments and Mutations
  • Statistical Methods in Clinical Trials
  • Pharmacogenetics and Drug Metabolism

The publications indicate a focus on pharmacoepidemiological methodologies, cancer survival analysis, and the impact of drug use on cancer risk. This reflects an interdisciplinary approach combining clinical epidemiology, biostatistics, and pharmacology, relevant for understanding drug-cancer associations and cancer prognosis.

Best Publications

  • Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

    Zdenek Skrott;Martin Mistrik;Klaus Kaae Andersen;Søren Friis

  • Risk of liver and other types of cancer in patients with cirrhosis : a nationwide cohort study in Denmark

    Henrik Toft Sørensen;Søren Friis;Jørgen H. Olsen;Ane Marie Thulstrup

  • Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

    Søren P. Johnsen;Heidi Larsson;Robert E. Tarone;Joseph K. McLaughlin

  • Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries

    S.C. Chuang;G. Scelo;J.M. Tonita;S. Tamaro

  • European Code against Cancer 4th edition: 12 ways to reduce your cancer risk §

    Joachim Schüz;Carolina Espina;Patricia Villain;Rolando Herrero

  • L-type calcium channel blockers and Parkinson disease in Denmark.

    Beate Ritz;Shannon L. Rhodes;Lei Qian;Eva Schernhammer

  • Cancer risk among statin users: a population-based cohort study.

    Søren Friis;Aslak H. Poulsen;Søren P. Johnsen;Søren P. Johnsen;Joseph K. McLaughlin

  • Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

    H T Sørensen;S Friis;B Nørgård;L Mellemkjær

  • Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality.

    T L Jørgensen;Jesper Hallas;S Friis;J Herrstedt

  • Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

    Sidsel Arnspang Pedersen;Sidsel Arnspang Pedersen;David Gaist;Sigrun Alba Johannesdottir Schmidt;Lisbet Rosenkrantz Hölmich

  • Risk of second cancer among women with breast cancer.

    Lene Mellemkjær;Søren Friis;Jørgen H. Olsen;Ghislaine Scélo

  • Atypical cancer pattern in patients with Parkinson's disease.

    JH Olsen;S Friis;K Frederiksen;JK McLaughlin

  • Confounding by indication in epidemiologic studies of commonly used analgesics.

    Lisa B Signorello;Joseph K McLaughlin;Loren Lipworth;Søren Friis

  • Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium

    Darren R. Brenner;Paolo Boffetta;Eric J. Duell;Heike Bickeböller

  • Surgical intervention and capsular contracture after breast augmentation: a prospective study of risk factors.

    Trine F. Henriksen;Jon P. Fryzek;Lisbet R. Holmich;Joseph K. Mclaughlin

  • Second Primary Cancers in Thyroid Cancer Patients: A Multinational Record Linkage Study

    Thekkepat C. Sandeep;Mark W.J. Strachan;Rebecca M. Reynolds;David H. Brewster

  • Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

    Søren Friis;Henrik T. Sørensen;Lene Mellemkjær;Joseph K. McLaughlin

  • A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

    S Friis;H T Sørensen;J K McLaughlin;S P Johnsen;S P Johnsen

  • Incidence of silicone breast implant rupture.

    Lisbet R. Hölmich;Søren Friis;Jon P. Fryzek;Ilse M. Vejborg

  • Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark

    Henrik Toft Sôrensen;Sôren Frus;Jôrgen H. Olsen;Ane Marie Thulstrup

Frequent Co-Authors

Henrik Toft Sørensen
Henrik Toft Sørensen Aarhus University
Joseph K. McLaughlin
Joseph K. McLaughlin Vanderbilt University Medical Center
Jesper Hallas
Jesper Hallas University of Southern Denmark
Jørgen H. Olsen
Jørgen H. Olsen Vanderbilt University Medical Center
Susanne K. Kjaer
Susanne K. Kjaer University of Copenhagen
Anne Tjønneland
Anne Tjønneland University of Copenhagen
William J. Blot
William J. Blot Vanderbilt University Medical Center
Loren Lipworth
Loren Lipworth Vanderbilt University Medical Center
Paolo Boffetta
Paolo Boffetta Stony Brook Medicine
Søren Paaske Johnsen
Søren Paaske Johnsen Aalborg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a career in medicine isn't always limited to becoming a doctor. Many students explore alternative or complementary degrees that prepare them for dynamic roles in healthcare. With advancements in technology and education, there are now diverse, accredited online programs to suit a variety of interests and goals.

Interested in leadership or healthcare management? Consider exploring a masters in healthcare administration cost to gain insight into affordable pathways toward executive positions. For registered nurses aiming to advance their clinical expertise, several accredited msn to dnp programs online can open doors to higher-level roles and greater autonomy.

Aspiring pharmacists can benefit from flexible learning with a pharmacy school online accredited program, providing both convenience and rigor. Additionally, those drawn to analytics or digital health should look into an online health information management degree, which is increasingly vital in today's data-driven healthcare system.

No matter your interests, these online programs offer practical and affordable pathways for building a rewarding healthcare career beyond traditional medical school.

Best Scientists Citing Søren Friis

Trending Scientists

Recently Published Articles